Back to IKT
MORGAN STANLEY IKT Position History
Inhibikase Therapeutics, Inc. • Healthcare
Quarters held
24
Latest value
$96K
Q3 2026
Peak value
$300K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $6K |
| Q3 2025 | $68K |
| Q3 2025 | $642 |
| Q3 2025 | $3K |
| Q3 2025 | $13K |
| Q4 2025 | $6K |
| Q4 2025 | $125K |
| Q4 2025 | $3K |
| Q4 2025 | $28K |
| Q1 2026 | $173K |
| Q1 2026 | $80K |
| Q1 2026 | $156 |
| Q1 2026 | $11K |
| Q1 2026 | $11K |
| Q2 2026 | $98K |
| Q2 2026 | $68K |
| Q2 2026 | $2K |
| Q2 2026 | $12K |
| Q2 2026 | $52K |
| Q3 2026 | $300K |
| Q3 2026 | $196K |
| Q3 2026 | $142 |
| Q3 2026 | $12K |
| Q3 2026 | $96K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $96K | 46.8K | — | — |
| Q3 2026 | $12K | 5.7K | — | — |
| Q3 2026 | $142 | 69 | — | — |
| Q3 2026 | $196K | 95.3K | — | — |
| Q3 2026 | $300K | 146.0K | — | — |
| Q2 2026 | $52K | 25.8K | — | — |
| Q2 2026 | $12K | 5.7K | — | — |
| Q2 2026 | $2K | 773 | — | — |
| Q2 2026 | $68K | 33.4K | — | — |
| Q2 2026 | $98K | 48.4K | — | — |
| Q1 2026 | $11K | 6.5K | — | — |
| Q1 2026 | $11K | 6.7K | — | — |
| Q1 2026 | $156 | 93 | — | — |
| Q1 2026 | $80K | 47.8K | — | — |
| Q1 2026 | $173K | 103.2K | — | — |
| Q4 2025 | $28K | 13.7K | — | — |
| Q4 2025 | $3K | 1.7K | — | — |
| Q4 2025 | $125K | 61.2K | — | — |
| Q4 2025 | $6K | 3.1K | — | — |
| Q3 2025 | $13K | 8.1K | — | — |
| Q3 2025 | $3K | 1.7K | — | — |
| Q3 2025 | $642 | 396 | — | — |
| Q3 2025 | $68K | 42.3K | — | — |
| Q3 2025 | $6K | 3.6K | — | — |